Mega%25252525252525252520cv

# Mega-CV (Amoxicillin/Potassium Clavulanate) ## Overview Mega-CV is a combination antibiotic consisting of amoxicillin (a beta-lactam) and potassium clavulanate (a beta-lactamase inhibitor). The clavulanate component extends the spectrum of amoxicillin to include beta-lactamase-producing bacteria. ## Primary Indications Treatment of infections caused by susceptible organisms, including community-acquired pneumonia, acute bacterial sinusitis, otitis media, skin and skin structure infections, and urinary tract infections. ## Adult Dosing * **Mild to Moderate Infections:** 500 mg amoxicillin/125 mg clavulanate every 8–12 hours. * **Severe Infections/Respiratory Tract Infections:** 875 mg amoxicillin/125 mg clavulanate every 12 hours. * **Maximum Dose:** Do not exceed 1750 mg of amoxicillin/250 mg of clavulanate per day (12-hour dosing) unless indicated by specific severe infection guidelines. * *Note: Dosing frequency varies by local protocol and severity of illness.* ## Pediatric Dosing * **General Dosage:** 20 mg/kg to 45 mg/kg per day (based on amoxicillin component), administered in divided doses every 8–12 hours. * **Recurrent/Resistant Otitis Media:** Up to 90 mg/kg/day (based on amoxicillin) divided twice daily, using specific high-dose formulations (e.g., 600 mg/5 mL suspension) to minimize clavulanate intake. * *Note: Always use weight-based calculations; never exceed adult maximums.* ## Dose Adjustments * **Renal Impairment:** Requires adjustment if CrCl < 30 mL/min. Avoid using the 875 mg tablet in patients with severe renal impairment (CrCl < 30 mL/min) as the clavulanate ratio is fixed. ## Contraindications * History of serious hypersensitivity (e.g., anaphylaxis) to penicillins or any component of the formulation. * History of cholestatic jaundice or hepatic dysfunction associated with previous use of amoxicillin/clavulanate. ## Adverse Effects * **Common:** Diarrhea (frequently associated with the clavulanate component), nausea, vomiting, skin rash, and moniliasis (yeast infection). * **Serious:** Severe hypersensitivity reactions (anaphylaxis), *Clostridioides difficile*-associated diarrhea (CDAD), and reversible cholestatic jaundice. ## Key Drug Interactions * **Methotrexate:** May decrease renal clearance, potentially increasing serum concentrations and toxicity. * **Warfarin:** May increase INR/bleeding risk by altering gut flora (vitamin K synthesis). * **Oral Contraceptives:** Potential for reduced efficacy (though evidence is debated, use of backup contraception is recommended). * **Probenecid:** Decreases renal excretion of amoxicillin, increasing serum levels. ## Monitoring * Monitor for signs of hypersensitivity (rash, wheezing). * Monitor for persistent diarrhea or signs of *C. difficile* infection. * Assess liver function tests (LFTs) if therapy is extended beyond 14 days. ## Clinical Pearls * **Administration:** Administer with a meal or snack to minimize gastrointestinal upset. * **Fixed Ratio:** The clavulanate content is fixed; increasing the dose of the tablet to achieve higher amoxicillin levels will inadvertently increase the clavulanate dose, potentially exacerbating diarrhea. * **Suspension:** Once reconstituted, oral suspensions typically require refrigeration and expire within 10 days. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice varies by institution and region. Always verify specific dosing, safety profiles, and current contraindications through official prescribing information (Package Insert), institutional formularies, or clinical decision support tools (e.g., Lexicomp, UpToDate) before prescribing or administering medication.